Protective Effects of Ipragliflozin, a Sodium-glucose Cotransporter 2 Inhibitor, on a Non-alcoholic Steatohepatitis Mouse Model

BACKGROUND: The options for the treatment of nonalcoholic steatohepatitis (NASH) are limited. We examined the effects of ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, on the fatty liver Shionogi (FLS)-ob/ob mice, a non-alcoholic steatohepatitis mouse model. METHODS: FLS-ob/ob male mice...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Yonago Acta Med
Päätekijät: Yamane, Masafumi, Matono, Tomomitsu, Okano, Jun-ichi, Nagahara, Ran, Matsuki, Yukako, Okamoto, Toshiaki, Miyoshi, Ken-ichi, Sugihara, Takaaki, Nagahara, Takakazu, Koda, Masahiko, Isomoto, Hajime
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Tottori University Faculty of Medicine 2019
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6437417/
https://ncbi.nlm.nih.gov/pubmed/30962742
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia